Company Overview of Marcadia Biotech, Inc.
Marcadia Biotech, Inc. discovers, develops, and commercializes drug candidates and biopharmaceutical products for the treatment of diabetes, obesity, and metabolic diseases. It has a strategic collaboration with Merck & Co., Inc. The company was formerly known as PhySci Pharmaceuticals, Inc. and changed its name to Marcadia Biotech, Inc. in 2006. The company was founded in 2005 and is based in Nutley, New Jersey. As of December 30, 2010, Marcadia Biotech, Inc. operates as a subsidiary of Roche Holding AG.
340 Kingsland Street
Nutley, NJ 07110-1199
Founded in 2005
Key Executives for Marcadia Biotech, Inc.
Marcadia Biotech, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Marcadia Biotech, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.